Schedule 13G ownership disclosure
ProQR Therapeutics NV
Security class unavailable · CUSIP: N71542109
Event date: 2023-09-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,280,865
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-100854
- Form type
- SC 13G
- Filer
- ProQR Therapeutics N.V.
- CIK
- CIK 1612940
- Filed
- Sep 14, 2023
- Reporting period
- Sep 11, 2023
- Description
- Schedule 13G beneficial ownership